BNR Stock Analysis: Buy, Sell, or Hold?
BNR - Burning Rock Biotech Limited American Depositary Shares
$9.82
0.86 (9.60%)
▲
5d:
+23.52%
30d:
+1.87%
90d:
-39.75%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jun 05, 2026
0d
Get Alerted When BNR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BNR shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: BNR shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: BNR is currently trading at $9.82, which is considered slightly high relative to its 30-day fair value range of $7.47 to $10.36.
Technical Outlook: Technically, BNR is in a strong downtrend. Immediate support is located at $7.00, while resistance sits at $10.20. The stock is showing strong short-term momentum, up 9.6% recently.
Market Sentiment: BNR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $4.03. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BNR is in a strong downtrend. Immediate support is located at $7.00, while resistance sits at $10.20. The stock is showing strong short-term momentum, up 9.6% recently.
Market Sentiment: BNR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $4.03. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$7.47 -
$10.36
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.6%)
- BEARISH: Trading 59.0% above Wall St target ($4.03)
Trading Range Analysis
30-Day Trading Range
$7.47 -
$10.36
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$7.00
Resistance Level
$10.20
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Wall Street Target
$4.03
(-59.0%)
Revenue Growth (YoY)
-18.9%
Profit Margin
-11.5%
Share & Embed Analysis
Last updated: July 02, 2026 9:40 PM ET
Data refreshes hourly during market hours. Next update: 10:40 PM
Data refreshes hourly during market hours. Next update: 10:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Yusheng Han
BUY
314870 shares
2026-03-31
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 64 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$144 | 61 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 54 HOLD |
